Jump to content

UK patients to get new HIV drug


Recommended Posts


The first in a new class of HIV drugs has become available in the UK.

It means doctors will have a further treatment option for patients who have built up resistance to existing drugs.

Raltegravir is an integrase inhibitor, which works by blocking an enzyme essential for HIV to be able to replicate itself.

An estimated 73,000 people live with HIV in the UK. Raltegravir will be reserved for those who have stopped responding to other treatment.

Resistance to HIV medication is becoming increasingly common - more than one in 10 UK patients with HIV has some level of resistance to at least one drug before they have even begun therapy, research has shown.

Link to comment

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

  • Create New...